ASC-930

N/A

Report date: 2022/07/04 19:38:02

Base Information

Drug NameASC-930

Drug Alias NamePlacenta-Derived Decidua Stromal Cell Therapy (ASC Therapeutics)ASC-930

ClassificationCell and gene therapy > Cell therapy > Somatic cell > Decidua stroma cell therapyCell and gene therapy > Cell therapy > Source of cells > Placenta-derived

Mechanisms of ActionCell replacements

TargetsNot applicable

Therapy Area/IndicationsGraft vs Host Disease

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsNo

Global Highest StatusPhase 2 Clinical

Highest Status in ChinaN/A

Originator CompaniesASC Therapeutics

China Registration ClassN/A

Develop Information

Active CompaniesASC Therapeutics

Inactive CompaniesN/A

Active IndicationsGraft vs Host Disease

Inactive IndicationsN/A

Other Information

ATC CodeN/A